(Abst.) PML after fingolimod treatment on: April 21, 2018, 02:57:03 pm #1 "Progressive multifocal leucoencephalopathy after fingolimod treatment"--from PubMed, April 21, 2018: Progressive multifocal leukoencephalopathy after fingolimod treatment - PubMed The risk of PML with fingolimod in the absence of prior natalizumab treatment is low. The estimated risk was 0.069 per 1,000 patients (95% confidence interval: 0.039-0.114), and the estimated incid... PubMed · ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
Complications from Gilenya treatment managed successfully, report says Reply #1 on: May 19, 2018, 04:21:31 pm #2 Here it is stated that there have been 13 Gilenya-related PML cases--"Complications from Gilenya treatment managed successfully, case report says" in Multiple Sclerosis News Today (May 16, 2018): Complications from Gilenya Managed Successfully, Case Report Says Read about a case study reporting the successful management of a MS patient who developed PML due to treatment with Gilenya. Multiple Sclerosis News Today · multiplesclerosisnewstoday.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
